Phillip G. Febbo, Chief Scientific & Med Officer at VERACYTE, INC. (VCYT), sold 19,460 shares at $36.16 ($703K) on 2026-03-02, disclosed to the SEC on 2026-03-04.
Scheduled sale ($703k) by Chief Scientific & Med Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.01 | 6,035 | $217K | 30.9% |
| 2 | $36.16 | 13,425 | $485K | 69.1% |
| Total | $36.11 avg | 19,460 | $703K | 100% |
| Filing → |
| VCYT | SELL | 2025-03-06 | $536K | — | Filing → |
| VCYT | SELL | 2024-12-06 | $347K | — | Filing → |
| ILMN | SELL | 2022-04-07 | $1.4M | — | Filing → |